LONDON, May 5, 2015 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Investor-Edge has initiated coverage on the following equities: Boston Scientific Corporation (NYSE: BSX), Abbott Laboratories (NYSE: ABT), Accuray Inc. (NASDAQ: ARAY), Zimmer Holdings Inc. (NYSE: ZMH), and Amedica Corporation (NASDAQ: AMDA). Free research report on Boston Scientific can be accessed at http://get.Investor-Edge.com/pdf/?c=Boston%20Scientific&d=05-May-2015&s=BSX. On Monday, May 04, 2015, the NASDAQ Composite ended at 5,016.93, up 0.23%, the Dow Jones Industrial Average advanced 0.26%, to finish the day at 18,070.40, and the S&P 500 closed at 2,114.49, up 0.29%. The gains were broad based as seven out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 844.94, up 0.59%, with the index also advancing 5.55% in the previous three months. Register for your complimentary reports at the links given below.

Boston Scientific Corp.'s stock edged 0.79% higher, to close Monday's session at $17.88, after oscillating between $17.79 and $18.03. The stock recorded a trading volume of 9.50 million shares, below its three months average volume of 12.50 million shares. Over the previous three trading sessions and the last three months, Boston Scientific Corp.'s shares have advanced 1.65% and 19.52%, respectively. Additionally, from the beginning of 2015, the stock has gained 34.94%. The company is trading above its 50-day and 200-day moving averages. The stock's 50-day moving average of $17.51 is above its 200-day moving average of $14.20. Furthermore, Boston Scientific Corp.'s stock traded at a PE ratio of 35.08 and has a Relative Strength Index (RSI) of 48.34. Sign up and read the free notes on BSX at:

http://get.Investor-Edge.com/pdf/?c=Boston%20Scientific&d=05-May-2015&s=BSX

Abbott Laboratories' stock finished Monday's session 0.66% higher at $47.00. A total of 3.07 million shares were traded, which was below its three months average volume of 5.21 million shares. The stock moved between $46.78 and $47.34 during the session. Abbott Laboratories' shares have advanced 1.89% in the last one month and 4.05% in the previous three months. Additionally, from the beginning of 2015, the stock has gained 4.40%. The company's shares are trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $47.01 is greater than its 200-day moving average of $44.37. Abbott Laboratories' stock traded at a PE ratio of 26.66 and has an RSI of 46.83. The complimentary notes on ABT can be downloaded as in PDF format at:

http://get.Investor-Edge.com/pdf/?c=Abbott%20Laboratories&d=05-May-2015&s=ABT

On Monday, shares in Accuray Inc. fluctuated between $6.61 and $7.00 before ending the session 2.71% higher at $7.00. The stock reported a trading volume of 4.23 million shares, above its three months average volume of 1.37 million shares. Accuray Inc.'s shares have declined 20.27% in the previous three trading sessions, 8.62% in the last three months and 7.28% on YTD basis. The company is trading below its 50-day and 200-day moving averages of $8.96 and $7.81, respectively. Moreover, shares of Accuray Inc. have an RSI of 16.28. Register for free on Investor-Edge and access the latest research on ARAY at:

http://get.Investor-Edge.com/pdf/?c=Accuray&d=05-May-2015&s=ARAY

Zimmer Holdings Inc.'s stock edged 0.23% higher, to close the day at $110.68. The stock recorded a trading volume of 1.30 million shares, above its three months average volume of 1.09 million shares. The stock oscillated between $110.41 and $111.65 during the session. Over the last three trading sessions and over the past three months, Zimmer Holdings Inc.'s shares have fallen by 4.04% and 4.19%, respectively. Furthermore, the stock has lost 2.42% since the start of this year. The company is trading above its 200-day moving average of $110.05, while the 200-day moving average is below Zimmer Holdings Inc.'s 50-day moving average of $117.32. Additionally, the stock traded at a PE ratio of 19.13 and has an RSI of 32.35. The complete research on ZMH is available for free at:

http://get.Investor-Edge.com/pdf/?c=Zimmer%20Holdings&d=05-May-2015&s=ZMH

On Monday, shares in Amedica Corp. recorded a trading volume of 3.40 million shares, higher than its three months average volume of 1.11 million shares. The stock ended the day at $0.26, which was 10.69% above its previous day's closing of $0.23, and registered an intraday range of $0.24 and $0.29. Amedica Corp.'s shares have lost 3.67% in the previous three trading sessions, 16.13% in the last one month and 67.50% on YTD basis. The company is trading below its 50-day and 200-day moving averages of $0.47 and $1.41, respectively. Furthermore, shares of Amedica Corp. have an RSI of 34.84. Free in depth research on AMDA is available at:

http://get.Investor-Edge.com/pdf/?c=Amedica&d=05-May-2015&s=AMDA

About Investor-Edge.com

At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

===============

EDITOR'S NOTES:

===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, sponsored by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

SOURCE Investor-Edge